Fresenius Medical Care AG & Co. KGaA announced that it has reached a settlement in principle to end an investigation of possible FCPA violations. The company disclosed in its regulatory filing that it has recorded charges of € 224 million encompassing estimates for the government’s claims for profit disgorgement, penalties, and incurred and expected legal expenses, impairments, and costs.
February 20, 2019
German dialysis equipment supplier reaches settlement in principle with US authorities in FCPA probe
Related by Topic
New Post
Former Nigerian National Petroleum employee convicted for his role in a bribery scheme
September 3, 2025
News Alert
New Post
Dutch regulator imposes €2.6 million fine on online bank for AML failures
September 1, 2025
News Alert